HKG:1466

2 stories mentioning HKG:1466Updated 39d ago

Every FINWIRES story that references HKG:1466, newest first.

Baijin Life Science Unit, Foryoung Tie Up for Clinical Cell Therapy Business

Baijin Life Science (HKG:1466) unit Beijing Baijin Biotechnology entered into an agreement with Foryoung Biotechnology for strategic cooperation, according to a Wednesday filing with the Hong Kong bourse.The parties will cooperate in the clinical cell therapy niche.Beijing Baijin Biotechnology will be responsible for the R&D, production, quality control, and global supply chain support of various products, with Foryoung Biotechnology integrating its technological capabilities in the process.

HKG:1466

Asia56d ago

Baijin Life Science Grants 67.9 Million Share Options

Baijin Life Science (HKG:1466) granted over 67.9 million share options to various directors and employees under a 2024 incentive scheme, according to a Friday Hong Kong bourse filing.The options are exercisable into an equal number of ordinary shares in the firm's share capital for five years at HK$0.54 apiece.The options are not subject to performance targets.The jewelry maker now has no shares available for future grant under the scheme.

HKG:1466

Track with the FINWIRES app suite

FolioX

Track HKG:1466 in your portfolio

WheelAI

Analyze HKG:1466 options with the wheel strategy

StockInsider

See market sentiment on HKG:1466